Abstract:A series of fifteen novel amide derivatives based on imidazo[1,2‐b]pyridazine scaffold were synthesized to yield good to excellentas lead compounds for antimicrobial activity. The molecular structures of the newly synthesized compounds were elucidated using spectroscopic techniques and supported by SXRD. These compounds were evaluated in vitro for antimicrobial activity against two Gram‐positive bacteria and two Gram‐negative bacteria. Some compounds exhibited significant antibacterial activity, which shown good correlation with In silco computational molecular docking study. A series of fifteen novel amide derivatives based on imidazo[1,2‐b]pyridazine scaffold were synthesized by taking imidazo[1,2‐b]pyridazine‐3‐carboxylic acid intermediates with respective substituted amines to yield good to excellent. The molecular structures of the newly synthesized compounds were elucidated using spectroscopic techniques (1H NMR, 13C NMR, and LCMS) and supported by single‐crystal X‐ray diffraction (SXRD) for the two compounds, 9 and 18. These compounds were evaluated in vitro for antimicrobial activity against two Gram‐positive bacteria (S. aureus and B. subtilis) and two Gram‐negative bacteria (E. coli and P. aeruginosa). Interestingly, compounds 10 and 16, displayed comparable antibacterial activity to the positive control (Tetracycline: 6.25 μg/mL) against Gram‐negative bacteria, particularly Pseudomonas aeruginosa, with a minimum inhibitory concentration (MIC) of 6.25 μg/mL. Compound 17 exhibited moderate antibacterial activity with an MIC of 10 μg/mL against the Gram‐positive bacterium Bacillus subtilis, whereas the positive control demonstrated an MIC of 6.25 μg/mL. These antibacterial activities were found to have a good correlation with Insilco computational molecular docking experiments using the receptor UDP‐N‐acetylglucosamine‐enolpyruvate reductase, Mtb MurB.

Synthesis of pyrrolidine‐fused β‐lactams as potential β‐lactamase inhibitors

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)

Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Synthesis of new bis(pyrazolo[1,5-a]pyrimidines) linked to different spacers with potential MurB inhibitory activity utilizing 1H-pyrazole-3,5-diamines

Synthesis of some pyrrolidine‐2,5‐dione derivatives with biological activity against Gram‐negative bacteria

Rational Design of Benzobisheterocycle Metallo-β-Lactamase Inhibitors: A Tricyclic Scaffold Enhances Potency against Target Enzymes

Synthesis of novel isoxazole/dihydroisoxazole tethered β-lactam hybrids via regiospecific 1,3-dipolar cycloaddition methodology on 3-phenylthio-β-lactams

Enantioselective synthesis of β-aryl-γ-lactam derivatives via Heck–Matsuda desymmetrization of N-protected 2,5-dihydro-1H-pyrroles

Synthetic studies on the tetrasubstituted D-ring of cystobactamids lead to potent terephthalic acid antibiotics

Enantioselective synthesis of β-aryl-γ-lactam derivatives via Heck–Matsuda desymmetrization of N -protected 2,5-dihydro-1 H -pyrroles

Direct Synthesis of Benzhydryl-Functionalized 3,4-Dihydropyridin-2-ones from 2-Pyridones and Their Use in the Formation of Bridged δ-Lactams

Design and enantioselective synthesis of 3-(-acrylic acid) benzoxaboroles to combat carbapenemase resistance

A new discovery towards novel skeleton of benzimidazole‐conjugated pyrimidinones as unique effective antibacterial agents

A ChemoEnzymatic Approach for the Preparation of "Linear‐Shaped" Diaryl Pyrazines as Potential Antiprotozoal Agents

Design, synthesis, and molecular dynamic simulations of some novel benzo[d]thiazoles with anti-virulence activity against Pseudomonas aeruginosa

Synthesis, crystal structure, DFT studies and biological activity of (Z)-3-(3-bromophenyl)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxyprop-2-en-1-one

Design, Synthesis and Antibacterial Activities of 5-(Pyrazin-2-yl)-4h-1,2,4-triazole-3-thiol Derivatives Containing Schiff Base Formation As FabH Inhibitory.

Synthesis of Imidazo[1,2‐b]pyridazine Scaffold Based Amide Derivatives as Potential Inhibitors for Bacterial Activity

Studies on Nonconventionally Fused Bicyclic Β-Lactams